Forms
PROJECT REGISTRATION AND AMENDMENTS
Institutional Biosafety Committee (IBC) members review projects; non-exempt projects are sent to the full IBC for review, comment, and approval.
The project submittal deadline is 5 pm on the first Wednesday of each month. [IBC Meeting schedules]
Summary of the NIH Guidelines will assist you in determining which category/categories your experiments fall under.
Type of Work |
Form |
All experiments involving the use of recombinant DNA (rDNA) |
|
Experiments involving: a) BSL-2 or BSL-3 human, animal, or plant pathogens.
|
|
Any work with biological toxins with a mammalian LD50 ≤ 100 µg/kg body weight |
|
Addition or deletion of project personnel or project location; termination of project |
|
Addition of a host, target recipient, gene insert, or methodology to existing rDNA registration |
|
Addition of a non-viral vector to existing rDNA registration |
|
Addition of a viral vector to existing rDNA registration |
|
Addition of a biological agent, host, or methodology to existing BA registration |
|
Addition of a toxin, host, or methodology to existing AT registration |
|
|
*The new use of rDNA in animals or new use of agents which fall under a different section of the NIH Guidelines for Research Involving Recombinant DNA Molecules than the original project approval will need to be reviewed and approved by the Institutional Biosafety Committee (IBC).
- Reference: IBC Meeting schedules
BIOPATH FORMS
|
BioPath: Biohazards Medical Monitoring Program |
BLOODBORNE PATHOGENS
|
2012 Bloodborne Pathogen Program and |
|
ANIMAL CONTACT
|
Animal Contact Medical Monitoring Program |